As of 1/01/2025, modifier TB will be required by Medicare for providers who bill separately Part B drugs and participate in the 340B Drug Pricing Program. Additional information can be found in the MLN Fact Sheet linked below.
As of 1/01/2025, modifier TB will be required by Medicare for providers who bill separately Part B drugs and participate in the 340B Drug Pricing Program. Additional information can be found in the MLN Fact Sheet linked below.